Bill Sponsor
Senate Bill 3233
116th Congress(2019-2020)
Hemophilia SNF Access Act
Introduced
Introduced
Introduced in Senate on Jan 28, 2020
Overview
Text
Introduced
Jan 28, 2020
Latest Action
Jan 28, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3233
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Jersey
Democrat
New Hampshire
Democrat
Rhode Island
Republican
Wyoming
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Hemophilia SNF Access Act

This bill includes certain treatments for hemophilia and other bleeding disorders as high-cost, low-probability ancillary services that may be paid for separately, rather than under the prospective payment (i.e., per diem) system for skilled nursing facilities, under Medicare.

Text (1)
January 28, 2020
Actions (2)
01/28/2020
Read twice and referred to the Committee on Finance.
01/28/2020
Introduced in Senate
Public Record
Record Updated
Feb 8, 2022 11:22:55 PM